IDYA

IDEAYA Biosciences, Inc.

IDYA · CIK 1676725 · Annual (10-K) · Last 7 years

Financial Trends

Revenue$219M
20192025
Net Income−$114M
20192025
Operating CF−$71M
20192025
Free Cash Flow−$73M
20192025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Revenue$0.2B$0.0B$0.0B$0.1B$0.0B$0.0B—
Cost of Revenue———————
Gross Profit———————
R&D Expense$0.3B$0.3B$0.1B$0.1B$0.1B$0.0B$0.0B
SG&A Expense———————
Operating Income$-0.2B$-0.3B$-0.1B$-0.1B$-0.1B$-0.0B$-0.0B
Net Income$-0.1B$-0.3B$-0.1B$-0.1B$-0.0B$-0.0B$-0.0B
EPS (Basic)$-1.28$-3.36$-1.96$-1.42———
EPS (Diluted)$-1.28$-3.36$-1.96$-1.42———

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Total Assets$1.1B$1.1B$0.6B$0.4B$0.4B$0.3B$0.1B
Current Assets$0.7B$0.7B$0.5B$0.4B$0.3B$0.3B$0.1B
Cash & Equivalents$0.1B$0.1B$0.2B$0.1B$0.1B$0.1B$0.0B
Total Liabilities$0.1B$0.1B$0.0B$0.0B$0.1B$0.1B$0.0B
Current Liabilities$0.1B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$1.0B$1.1B$0.6B$0.3B$0.3B$0.2B$0.1B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Operating Cash Flow$-0.1B$-0.2B$-0.1B$-0.1B$-0.1B$0.1B$-0.0B
Investing Cash Flow$0.1B$-0.5B$-0.2B$-0.0B$-0.1B$-0.1B$0.0B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.0B$0.7B$0.4B$0.1B$0.1B$0.1B$0.1B
← Companies